Cost-benefit analysis of rubella screening.
D000914:Antibodies, Viral / Q000032:analysis*; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D011247:Pregnancy; D012409:Rubella / Q000151:congenital / Q000517:prevention & control*; D012412:Rubella virus / Q000276:immunology*; D014481:United States
D000914:Antibodies, Viral